90 related articles for article (PubMed ID: 9469338)
1. Second cancers following pediatric Hodgkin's disease.
Wolden SL; Lamborn KR; Cleary SF; Tate DJ; Donaldson SS
J Clin Oncol; 1998 Feb; 16(2):536-44. PubMed ID: 9469338
[TBL] [Abstract][Full Text] [Related]
2. Second cancers in Hodgkin's lymphoma long-term survivals: A 60-year single institutional experience with real-life cohort of 871 patients.
Petrakova K; Vyskocil J; Grell P; Majek O; Soumarova R; Novak J; Burkon P; Kral Z; Kazda T; Vyzula R
Int J Clin Pract; 2018 Jul; ():e13235. PubMed ID: 30011112
[TBL] [Abstract][Full Text] [Related]
3. Excellent results of screening for subsequent breast cancers in long-term survivors of childhood Hodgkin's lymphoma-Results of a population-based study.
Zadravec Zaletel L; Cesen Mazic M; Jazbec J; Kos G; Toplak M; Štrbac D
Front Pediatr; 2023; 11():1161128. PubMed ID: 37077334
[TBL] [Abstract][Full Text] [Related]
4. Case report: Pulmonary synovial sarcoma in a long-term survivor of childhood Hodgkin lymphoma.
Shilo K; Kneuertz PJ; Liebner D; Chen W
Front Oncol; 2023; 13():1096160. PubMed ID: 36910640
[TBL] [Abstract][Full Text] [Related]
5. Vital organ sparing with proton therapy for pediatric Hodgkin lymphoma: Toxicity and outcomes in 50 patients.
Tringale KR; Modlin LA; Sine K; Forlenza CJ; Cahlon O; Wolden SL
Radiother Oncol; 2022 Mar; 168():46-52. PubMed ID: 35101461
[TBL] [Abstract][Full Text] [Related]
6. Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies.
Zahnreich S; Schmidberger H
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34073340
[TBL] [Abstract][Full Text] [Related]
7. Early Radiation-Induced Sarcoma in an Adolescent Treated for Relapsed Hodgkin Lymphoma with Nivolumab.
Šalaševičius L; Vaitkevičienė GE; Pasaulienė R; Kiudelienė R; Ivanauskaitė-Didžiokienė E; Vajauskas D; Jurkienė N; Rascon J
Medicina (Kaunas); 2020 Mar; 56(4):. PubMed ID: 32244416
[TBL] [Abstract][Full Text] [Related]
8. Adolescent and young adult Hodgkin lymphoma: Raising the bar through collaborative science and multidisciplinary care.
Kahn JM; Kelly KM
Pediatr Blood Cancer; 2018 Jul; 65(7):e27033. PubMed ID: 29603618
[TBL] [Abstract][Full Text] [Related]
9. The value of FATS expression in predicting sensitivity to radiotherapy in breast cancer.
Zhang J; Wu N; Zhang T; Sun T; Su Y; Zhao J; Mu K; Jin Z; Gao M; Liu J; Gu L
Oncotarget; 2017 Jun; 8(24):38491-38500. PubMed ID: 28402275
[TBL] [Abstract][Full Text] [Related]
10. Thyroid neoplasms: incidental findings on extent of disease evaluation CT for other pediatric malignancies.
Hammond WJ; Heaton TE; Farber BA; Mahmood UA; Gluskin JS; Wolden SL; La Quaglia MP; Sklar CA; Price AP
J Pediatr Surg; 2017 Jun; 52(6):938-943. PubMed ID: 28347527
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic Characteristics and Prognosis of Tongue Squamous Cell Carcinoma in Patients with and without a History of Radiation for Nasopharyngeal Carcinoma: A Matched Case-Control Study.
Zhang P; Zhang L; Liu H; Zhao L; Li Y; Shen JX; Liu Q; Liu MZ; Xi M
Cancer Res Treat; 2017 Jul; 49(3):695-705. PubMed ID: 27737535
[TBL] [Abstract][Full Text] [Related]
12. Pediatric Hodgkin lymphoma: biomarkers, drugs, and clinical trials for translational science and medicine.
Nagpal P; Akl MR; Ayoub NM; Tomiyama T; Cousins T; Tai B; Carroll N; Nyrenda T; Bhattacharyya P; Harris MB; Goy A; Pecora A; Suh KS
Oncotarget; 2016 Oct; 7(41):67551-67573. PubMed ID: 27563824
[TBL] [Abstract][Full Text] [Related]
13. Late Toxicities of Intensity-Modulated Radiation Therapy for Head and Neck Rhabdomyosarcoma.
Lockney NA; Friedman DN; Wexler LH; Sklar CA; Casey DL; Wolden SL
Pediatr Blood Cancer; 2016 Sep; 63(9):1608-14. PubMed ID: 27195454
[TBL] [Abstract][Full Text] [Related]
14. Minimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children's Oncology Group.
Appel BE; Chen L; Buxton AB; Hutchison RE; Hodgson DC; Ehrlich PF; Constine LS; Schwartz CL
J Clin Oncol; 2016 Jul; 34(20):2372-9. PubMed ID: 27185849
[TBL] [Abstract][Full Text] [Related]
15. Secondary Neoplasms in Children with Hodgkin's Lymphoma Receiving C-MOPP and Radiotherapy: Presentation of Four Cases.
Gözdaşoğlu S; Pamir A; Ünal E; Gökçora İH; Uluoğlu Ö; Ceyhan K; Deda H; Işıkman E; Yavuz G; Taçyıldız N; Çavdar A
Turk J Haematol; 2016 Mar; 33(1):66-70. PubMed ID: 26377258
[TBL] [Abstract][Full Text] [Related]
16. Secondary Malignancies Following Treatment for Hodgkin's Lymphoma in Childhood and Adolescence.
Dörffel W; Riepenhausenl M; Lüders H; Brämswig J; Schellong G
Dtsch Arztebl Int; 2015 May; 112(18):320-7, i. PubMed ID: 26037468
[TBL] [Abstract][Full Text] [Related]
17. Minimizing second cancer risk following radiotherapy: current perspectives.
Ng J; Shuryak I
Cancer Manag Res; 2015; 7():1-11. PubMed ID: 25565886
[TBL] [Abstract][Full Text] [Related]
18. Novel radiotherapy techniques for involved-field and involved-node treatment of mediastinal Hodgkin lymphoma: when should they be considered and which questions remain open?
Lohr F; Georg D; Cozzi L; Eich HT; Weber DC; Koeck J; Knäusl B; Dieckmann K; Abo-Madyan Y; Fiandra C; Mueller RP; Engert A; Ricardi U
Strahlenther Onkol; 2014 Oct; 190(10):864-6, 868-71. PubMed ID: 25209551
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating risk.
Braunstein S; Nakamura JL
Front Oncol; 2013; 3():73. PubMed ID: 23565507
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer surveillance in patients treated by radiotherapy for Hodgkin's lymphoma.
Mariscotti G; Durando M; Ghione G; Luparia A; Regini E; Alfieri C; Campanino PP; Gavarotti P; Brignardello E; Gandini G
Radiol Med; 2013 Apr; 118(3):401-14. PubMed ID: 22872454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
